Liver resection is an important surgical treatment for patients with liver diseases. Despite advances in surgical and anesthetic management, postoperative complications remain a major concern and may affect patient recovery. Maintaining stable blood circulation during surgery is an important part of perioperative care.
Terlipressin is a vasoactive medication that may help maintain blood pressure and improve hemodynamic stability during surgery. However, the relationship between intraoperative continuous terlipressin infusion and postoperative outcomes after laparoscopic hepatectomy remains unclear.
This prospective observational cohort study aims to evaluate the association between continuous intraoperative terlipressin infusion and postoperative severe complications in patients undergoing laparoscopic hepatectomy.
Patients undergoing laparoscopic hepatectomy at the First Affiliated Hospital of Sun Yat-sen University will be enrolled and followed according to a predefined study protocol. Perioperative clinical information, anesthetic management data, terlipressin exposure, and postoperative outcomes will be collected and analyzed. The primary outcome is the occurrence of severe postoperative complications, defined as Clavien-Dindo grade III or higher complications.
Inclusion Criteria:
Exclusion Criteria:
Patients who received continuous intraoperative terlipressin infusion during laparoscopic hepatectomy according to the clinical judgment of the attending anesthesiologist. Terlipressin administration was not assigned by the study protocol and was determined based on routine clinical practice.
Patients who underwent laparoscopic hepatectomy and did not receive continuous intraoperative terlipressin infusion during surgery. The absence of terlipressin administration was determined by routine clinical practice.
Guangzhou, Guangdong 510080, China
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
Terlipressin Administration in Patients Undergoing Major Liver Resection
Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.
Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients
Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery
Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
Does Terlipressin Improve Renal Outcome After Liver Surgery
Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection